The emerging role for repetitive transcranial magnetic stimulation in optimizing the treatment of adolescent depression

Journal of ECT

Volumn 26, Issue 4, 2010, Pages 323-329

  Croarkin, Paul E ^a   Wall, Christopher A ^b   McClintock, Shawn M ^a,c   Kozel, Frank Andrew ^a   Husain, Mustafa M ^a   Sampson, Shirlene M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

adolescents; major depressive disorder; transcranial magnetic stimulation

Indexed keywords

CLOZAPINE;

ADOLESCENT; ATTENTION DEFICIT DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EARLY INTERVENTION; FEASIBILITY STUDY; HUMAN; MAJOR DEPRESSION; NEUROMODULATION; REVIEW; SAFETY; SCHIZOPHRENIA; SEIZURE; THERAPY EFFECT; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ADULT; CHILD; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; HUMANS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 78650512366     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3181dd17eb     Document Type: Review

References (82)

1. Birmaher B, Brent D, et al, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry. 2007;46:1503-1526.
2. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007;64:1132-1143.
3. Walter G, Rey JM. An epidemiological study of the use of ECT in adolescents. J Am Acad Child Adolesc Psychiatry. 1997;36:809-815.
4. Loo C, McFarquhar T, Walter G. Transcranial magnetic stimulation in adolescent depression. Australas Psychiatry. 2006;14:81-85.
5. Bloch Y, Grisarv N, Harel EV, et al. Repetitive transcranial magnetic stimulation in the treatment of depression in adolescents: an open-label study. J ECT. 2008;24:156-159.
6. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5:73-103.
7. Holtzheimer PE 3rd, Russo J, Avery DH. A meta-analysis of repetitive transcranial magnetic stimulation in the treatment of depression. Psychopharmacol Bull. 2001;35:149-169.
8. Kozel FA, George MS. Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract. 2002;8:270-275.
9. McNamara B, Ray JL, Arthurso J, et al. Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychol Med. 2001;31:1141-1146.
10. Walter G, Tormos JM, Israel JA, et al. Transcranial magnetic stimulation in young persons: a review of known cases. J Child Adolesc Psychopharmacol. 2001;11:69-75.
11. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299:901-913.
12. Herrmann LL, Ebmeier KP. Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry. 2006;67:1870-1876.
13. Couturier JL. Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci. 2005;30:83-90.
14. Gross M, Nakamura L, Pascual-Leone A, et al. Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand. 2007;116:165-173.
15. Lam RW, Chan P, Wilkins-Ho M, et al. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry. 2008;53:621-631.
16. O'Reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208-1216.
17. Tormos JM, Catala, Pascual-Leone A. Transcranial magnetic stimulation. Rev Neurol. 1999;29:165-171.
18. Fitzgerald PB, Benitez J, Daskalakis ZJ, et al. The treatment of recurring auditory hallucinations in schizophrenia with rTMS. Wo r l d J Biol Psychiatry. 2006;7:119-122.
19. Schutter DJ, van Honk J. A framework for targeting alternative brain regions with repetitive transcranial magnetic stimulation in the treatment of depression. J Psychiatry Neurosci. 2005;30:91-97.
20. Fitzgerald PB, Benitez J, deCastella A, et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry. 2006;163:88-94.
21. Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder: a review. Can J Psychiatry. 2008;53:555-566.
22. Lisanby SH, Husain MM, Rosenquist PB, et al. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009;34:522-534.
23. Fregni F, Marcolin MA, Myczkowski M, et al. Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation. Int J Neuropsychopharmacol. 2006;9:641-654. (Pubitemid 46127397)
24. Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008;69:441-451.
25. Wassermann EM. Side effects of repetitive transcranial magnetic stimulation. Depress Anxiety. 2000;12:124-129.
26. Tharayil BS, Gangadhar BN, Thirthalli J, et al. Seizure with single-pulse transcranial magnetic stimulation in a 35-year-old otherwise-healthy patient with bipolar disorder. J ECT. 2005;21: 188-189.
27. Wassermann EM. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol. 1998;108:1-16.
28. Rossi S, Hallet M, Rossini PM, et al. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol. 2009;120:2008-2039.
29. Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, et al. Seizure induction and transcranial magnetic stimulation. Lancet. 1992;339:997.
30. Loo C, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol. 2008;11:131-147.
31. Weber M, Eisen AA. Magnetic stimulation of the central and peripheral nervous systems. Muscle Nerve. 2002;25:160-175.
32. Martis B, Alam D, Down SM, et al. Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol. 2003;114:1125-1132.
33. Pascual-Leone A, Cohen AG, Shotland LI, et al. No evidence of hearing loss in humans due to transcranial magnetic stimulation. Neurology. 1992;42:647-651.
34. Loo C, Sachdev P, Elsayed H, et al. Effects of a 2- to 4-week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychologic functioning, electroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry. 2001;49:615-623.
35. Molnar GF, Sailer A, Gunraj CA, et al. Changes in cortical excitability with thalamic deep brain stimulation. Neurology. 2005;64:1913-1919.
36. Siebner HR, Dressnandt J, Auer C, et al. Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia. Muscle Nerve. 1998;21:1209-1212.
37. Janicak PG, O'Reardon JP, Sampson SM, et al. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry. 2008;69:222-232.
38. Walter G, Martin J, Kirkby K, et al. Transcranial magnetic stimulation: experience, knowledge and attitudes of recipients. Aust N Z J Psychiatry. 2001;35:58-61.
39. Martin A, Cohen DJ. Adolescent depression: window of (missed?) opportunity. Am J Psychiatry. 2000;157:1549-1551.
40. Lewinsohn PM, Rohde P, Seeley JR, et al. Natural course of adolescent major depressive disorder in a community sample: predictors of recurrence in young adults. Am J Psychiatry. 2000;157: 1584-1591.
41. Ryan ND, Williamson DE, Iyengar S, et al. A secular increase in child and adolescent onset affective disorder. J Am Acad Child Adolesc Psychiatry. 1992;31:600-605.
42. Jeffery DA, Sava DB, Winters NC. Depressive disorders. In: Cheng K, Myers KM, eds. Child and Adolescent Psychiatry. Philadelphia, PA: Lippincott Williams and Wilkins; 2005:169-189.
43. Weisz JR, McCarty CA, Valeri SM. Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull. 2006;132:132-149.
44. Harrington R, Campbell F, Shoebridge P, et al. Meta-analysis of CBT for depression in adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37:1005-1007.
45. Compton SN, March JS, Brent D, et al. Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry. 2004;43:930-959.
46. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292:807-820. (Pubitemid 39079667)
47. Mufson L, Weissman MM, Moreau D, et al. Efficacy of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 1999;56:573-579.
48. Mufson L, Dorta KP, Wickramaratne P, et al. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry. 2004;61:577-584. (Pubitemid 38747312)
49. Rossello J, Bernal G. The efficacy of cognitive-behavioral and interpersonal treatments for depression in Puerto Rican adolescents. J Consult Clin Psychol. 1999;67:734-745.
50. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007;297:1683-1696.
51. Hughes CW, Emslie GJ, Crimson ML, et al. Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:667-686.
52. Cheung AH, Emslie GJ, Mayes TL. Review of the efficacy and safety of antidepressants in youth depression. J Child Psychol Psychiatry. 2005;46:735-754.
53. Kennard B, Silva S, Vitello B, et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry. 2006;45:1404-1411. (Pubitemid 44900913)
54. Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. 1997;54:1031-1037.
55. Ghaziuddin N, Kutcher SP, Knapp P, et al. Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry. 2004;43:1521-1539.
56. Walter G, Rey WM. Has the practice and outcome of ECT in adolescents changed? Findings from a whole-population study. J ECT. 2003;19:84-87.
57. Cohen D, Taieb O, Flament M, et al. Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry. 2000;157:460-462.
58. Walter G, Koster K, Rey JM. Electroconvulsive therapy in adolescents: experience, knowledge, and attitudes of recipients. J Am Acad Child Adolesc Psychiatry. 1999;38:594-599.
59. Taieb O, Cohen D, Mazet P, et al. Adolescents' experiences with ECT. J Am Acad Child Adolesc Psychiatry. 2000;39:943-944.
60. Doane JA, Falloon IR, Goldstein MJ, et al. Parental affective style and the treatment of schizophrenia. Predicting course of illness and social functioning. Arch Gen Psychiatry. 1985;42:34-42.
61. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
62. Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003;60:49-56.
63. Shaffer D, Gould MS, Brasic J, et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40:1228-1231.
64. Jardri R, Lucas B, Delevoye-Turell Y, et al. An 11-year-old boy with drug-resistant schizophrenia treated with temporo-parietal rTMS. Mol Psychiatry. 2007;12:320.
65. Weaver L, Mace W, Akhtar, et al. Safety and efficacy of rTMS in treatment of ADHD in adolescents and young persons. J ECT. 2008;24:105-106.
66. McGoey KE, DuPaul GJ, Haley E, et al. Parent and teacher ratings of attention-deficit/hyperactivity disorder in preschool: the ADHD Rating Scale-IV Preschool Version. J Psychopathol Behav Assess. 2007;29:269-276.
67. Morales OG, Henry ME, Nobler MS, et al. Electroconvulsive therapy and repetitive transcranial magnetic stimulation in children and adolescents: a review and report of two cases of epilepsia partialis continua. Child Adolesc Psychiatr Clin N Am. 2005;14(1):193-210.
68. Rotenberg A, Depositario-Cabacar D, Bae EH, et al. Transient suppression of seizures by repetitive transcranial magnetic stimulation in a case of Rasmussen's encephalitis. Epilepsy Behav. 2008;13(1):260-262.
69. Lin KL, Pascual-Leone A. Transcranial magnetic stimulation and its applications in children. Chang Gung Med J. 2002;25:424-436.
70. Garvey MA, Ziemann U, Bartko JJ, et al. Cortical correlates of neuromotor development in healthy children. Clin Neurophysiol. 2003;114:1662-1670.
71. Quintana H. Transcranial magnetic stimulation in persons younger than the age of 18. J ECT. 2005;21:88-95.
72. Garvey MA. Transcranial magnetic stimulation studies in children. In: Hallet M, Chokroverty S, eds. Magnetic Stimulation in Clinical Neurophysiology. Philadelphia, PA: Elsevier Inc; 2005:429-433.
73. Gilbert DL, Garvey MA, Bansal AS, et al. Should transcranial magnetic stimulation research in children be considered minimal risk? Clin Neurophysiol. 2004;115:1730-1739.
74. Collado-Corona MA, Mora-Magana I, Cordero GL, et al. Transcranial magnetic stimulation and acoustic trauma or hearing loss in children. Neurol Res. 2001;23:343-346.
75. Nahas Z, DeBrux C, Chandler V, et al. Lack of significant changes on magnetic resonance scans before and after 2 weeks of daily left prefrontal repetitive transcranial magnetic stimulation for depression. J ECT. 2000;16:380-390.
76. Niehaus L, Hoffman KT, Grosse P, et al. MRI study of human brain exposed to high-dose repetitive magnetic stimulation of visual cortex. Neurology. 2000;54:256-258.
77. Li X, Nahas Z, Lomareu M, et al. Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression. Cogn Behav Neurol. 2003;16:128-135.
78. Gates JR, Dhuna A, Pascual-Leone A. Lack of pathologic changes in human temporal lobes after transcranial magnetic stimulation. Epilepsia. 1992;33:504-508.
79. Frye RE, Rotenberg A, Ousley M, et al. Transcranial magnetic stimulation in child neurology current and future directions. J Child Neurol. 2008;23(1):79-96.
80. Ebmeier KP, Herrmann LL. TMSVthe beginning of the end or the end of the beginning? Psychol Med. 2008;38:319-321.
81. Rowell M, Zlotkin S. The ethical boundaries of drug research in pediatrics. Pediatr Clin North Am. 1997;44:27-40.
82. Garvey MA, Kaczynski KJ, Becker DA, et al. Subjective reactions of children to single-pulse transcranial magnetic stimulation. J Child Neurol. 2001;16:891-894.